9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
Adela, Inc
IGM Biosciences, Inc.
Ipsen
Taproot Health
Deciphera Pharmaceuticals, LLC
Sumitomo Pharma America, Inc.
Celgene
Acrotech Biopharma Inc.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
INSYS Therapeutics Inc